Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on September 2, 2020. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Characterization of ten (10) Adenovirus type 5 (Ad5) Vaccine Vectors

Closed
N3239820RCA0031Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 21 days

General Info

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Silver Spring, MD, 20910, USA

Set-Aside

SBA

Documents

1

JAA+N3239820RCA0031-.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Naval Medical Research Center
Contacts2 people available
OfficeSILVER SPRING, MD, 20910-7500, USA
Office AddressSILVER SPRING, MD, 20910-7500, USA

Full Description

Show more
The Naval Medical Research Center (NMRC) intends to award a sole source contract to OD 260 Inc. This is not a request for competitive proposals; however, if interested, the Government shall consider all responses. The requirement is for the generation, amplification, purification, titration, and characterization of ten (10) Adenovirus type 5 (Ad5) vaccine vectors, generated using the AdenoQuick 2.0 system, expressing ten different Plasmodium yoelii malaria antigens. POP 12 months.

More opportunities from Department Of Defense → Naval Medical Research Center

Same awarding agency

NAICS: 811210
Federal
Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000
Solicitation # N3239826Q4072
The Naval Medical Research Command is awarding a sole source, firm fixed price contract to Illumina Inc. for a comprehensive full-service maintenance and repair plan for the Illumina NovaSeq 6000 sequencing instrument (S/N A01716 / ECN 108501). The period of performance runs from January 12, 2026, to January 11, 2027, divided into four quarterly support segments. As the original equipment manufacturer, Illumina is designated as the only authorized source capable of providing the required certified technicians and proprietary support. The NovaSeq 6000 Silver Support Plan includes full coverage for OEM parts, labor, and travel, as well as the no-cost replacement of proprietary reagents lost during hardware failure. Key deliverables include one on-site preventative maintenance visit, remote technical support available Monday through Friday from 0600 to 1800, and an on-site response time within two business days of a hardware performance issue. The agreement also covers OEM field modifications, safety inspections, and software updates at no additional cost to the government. Performance will take place at the NMRC-Frederick facility at Fort Detrick, Maryland, with administrative oversight based in Silver Spring, Maryland. The contractor must adhere to strict operational security and information protection guidelines regarding sensitive unclassified information and personally identifiable information. Invoicing and payment requests are to be processed through the Wide Area Work Flow system.
Electronic and Precision Equipment Repair and Maintenance

POSTED

10 months ago

DEADLINE

in 2 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS